Healthcare -
Biotechnology - NASDAQ - US
$ 74.17
1.57 %
$ 9.55 B
Market Cap
-19.52
P/E
PCVX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization PCVX - Vaxcyte, Inc.
10.2 M
LAST VALUE
71.53%
2 YEAR CAGR
57.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR